Patents by Inventor Hon Leong

Hon Leong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11672866
    Abstract: The present disclosure is directed to protocells or nanoparticles, which are optionally coated with a lipid bilayer, which can be used for targeting bone tissue for the delivery of bioactive agents useful in the treatment and/or diagnosis of bone cancer, often metastatic bone cancer which often occurs secondary to a primary cancer such as prostate cancer, breast cancer, lung cancer and ovarian cancer, among numerous others. These protocells or nanoparticles target bone cancer especially metastatic bone cancer with bioactive agents including anticancer agents and/or diagnostic agents for purposes of treating, diagnosing and/or monitoring the therapy of the bone cancer. Osteotropic protocells or nanoparticles, pharmaceutical compositions comprising a population of osteotropic protocells or nanoparticles and methods of diagnosing, treating and/or monitoring therapy of bone cancer are representative aspects.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: June 13, 2023
    Inventors: Paul N. Durfee, Charles Jeffrey Brinker, Yu-Shen Lin, Hon Leong
  • Publication number: 20190022235
    Abstract: The present disclosure is directed to protocells or nanoparticles, which are optionally coated with a lipid bilayer, which can be used for targeting bone tissue for the delivery of bioactive agents useful in the treatment and/or diagnosis of bone cancer, often metastatic bone cancer which often occurs secondary to a primary cancer such as prostate cancer, breast cancer, lung cancer and ovarian cancer, among numerous others. These protocells or nanoparticles target bone cancer especially metastatic bone cancer with bioactive agents including anticancer agents and/or diagnostic agents for purposes of treating, diagnosing and/or monitoring the therapy of the bone cancer. Osteotropic protocells or nanoparticles, pharmaceutical compositions comprising a population of osteotropic protocells or nanoparticles and methods of diagnosing, treating and/or monitoring therapy of bone cancer are representative aspects.
    Type: Application
    Filed: January 6, 2017
    Publication date: January 24, 2019
    Inventors: Paul N. Durfee, Charles Jeffrey Brinker, Yu-shen Lin, Hon Leong
  • Patent number: 6696832
    Abstract: An apparatus and associated testing method for identifying void heads in magnetic storage systems in which a first bit error rate is determined using data written at a first overshoot amount. A second bit error rate is determined using data written at a second rate current in a second overshoot amount. A physically damaged transducer head is identified based upon a comparison of the first bit error rate to the second bit error rate.
    Type: Grant
    Filed: September 30, 2002
    Date of Patent: February 24, 2004
    Assignee: Seagate Technology LLC
    Inventors: Victor W K Chew, Edward Y K Hew, David K L Loh, Myint Ngwe, Wong Hon Leong, Say Kwee Teck
  • Publication number: 20030184286
    Abstract: An apparatus and associated testing method for identifying void heads in magnetic storage systems in which a first bit error rate is determined using data written at a first overshoot amount. A second bit error rate is determined using data written at a second rate current in a second overshoot amount. A physically damaged transducer head is identified based upon a comparison of the first bit error rate to the second bit error rate.
    Type: Application
    Filed: September 30, 2002
    Publication date: October 2, 2003
    Inventors: Victor Wk Chew, Edward Yk Hew, David KL Loh, Myint Ngwe, Wong Hon Leong, Say Kwee Teck